Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)

Ji Suk Han, Mi Jung Lee, Kyoung Sook Park, Seung Hyeok Han, Tae-Hyun Yoo, Kook-Hwan Oh, Sue Kyung Park, Joongyub Lee, Young Youl Hyun, Wookyung Chung, Yeong Hoon Kim, Curie Ahn, Kyu Hun Choi, Ji Suk Han, Mi Jung Lee, Kyoung Sook Park, Seung Hyeok Han, Tae-Hyun Yoo, Kook-Hwan Oh, Sue Kyung Park, Joongyub Lee, Young Youl Hyun, Wookyung Chung, Yeong Hoon Kim, Curie Ahn, Kyu Hun Choi

Abstract

Background: Anemia is a common complication among patients with chronic kidney disease (CKD), and it is associated with unfavorable clinical outcomes in patients with CKD independent of the estimated glomerular filtration rate (eGFR). We assessed the association of the urinary albumin-to-creatinine ratio (ACR) and eGFR with anemia in CKD patients.

Methods: We conducted a cross-sectional study using baseline data from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD). Multiple regression analysis was performed to identify the independent association of albuminuria with anemia. Furthermore, odds ratios for anemia were calculated by cross-categorization of ACR and eGFR.

Results: Among 1,456 patients, the mean age was 53.5 ± 12.4 years, and the mean eGFR and ACR were 51.9 ± 30.5 mL/min per 1.73 m2 and 853.2 ± 1,330.3 mg/g, respectively. Anemia was present in 644 patients (40.5%). Multivariate analysis showed that the odds ratio of anemia increased according to ACR levels, after adjusting for age, sex, eGFR, body mass index, pulse pressure, cause of CKD, use of erythropoiesis stimulating agents, serum calcium and ferritin (ACR < 30 mg/g as a reference group; 30-299 mg/g, adjusted odds ratio (OR) = 1.43, 95% confidence interval (CI) = 0.88-2.33; ≥300 mg/g, adjusted OR = 1.86, 95% CI = 1.12-3.10). In addition, graded associations were observed in cross-categorized groups of a higher ACR and eGFR compared to the reference group with an ACR <30 mg/g and eGFR ≥60 mL/min per 1.73 m2.

Conclusion: The present study demonstrated that albuminuria was a significant risk factor for anemia in CKD patients independent of the eGFR.

Trial registration: ClinicalTrials.gov NCT01630486.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Correlation of hemoglobin levels with…
Fig 1. Correlation of hemoglobin levels with albuminuria.
Hemoglobin levels are inversely related with Ln ACR levels (r = -0.281, P Abbreviation: ACR, albumin-to-creatinine ratio; Ln ACR, log-transformed albumin-to-creatinine ratio
Fig 2. The risk of anemia in…
Fig 2. The risk of anemia in relation to the ACR and eGFR.
By using generalized additive models, the risk (solid line) and 95% confidence intervals (dashed line) of anemia in relation to the (A) ACR and (B) eGFR is estimated. Abbreviations: ACR, albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate.

References

    1. Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P. Estimated GFR, Albuminuria, and Complications of Chronic Kidney Disease. Journal of the American Society of Nephrology. 2011;22(12):2322–31. 10.1681/asn.2010111181
    1. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Archives of internal medicine. 2002;162(12):1401–8. Epub 2002/06/22. .
    1. Babazono T, Hanai K, Suzuki K, Kiuchi Y, Inoue A, Tanaka M, et al. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia. 2006;49(6):1387–93. Epub 2006/04/14. 10.1007/s00125-006-0247-y .
    1. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney international. 2006;69(3):560–4. Epub 2006/01/06. 10.1038/sj.ki.5000105 .
    1. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. Journal of the American College of Cardiology. 2001;38(4):955–62. Epub 2001/10/05. .
    1. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. Journal of the American Society of Nephrology: JASN. 2005;16(6):1803–10. Epub 2005/04/29. 10.1681/asn.2004070597 .
    1. Bernhardt WM, Wiesener MS, Scigalla P, Chou J, Schmieder RE, Gunzler V, et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. Journal of the American Society of Nephrology: JASN. 2010;21(12):2151–6. Epub 2010/12/01. 10.1681/asn.2010010116 ; PubMed Central PMCID: PMCPmc3014028.
    1. Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized Anemia in Patients With Diabetes A cross-sectional survey. Diabetes care. 2003;26(4):1164–9.
    1. Adetunji OR, Mani H, Olujohungbe A, Abraham KA, Gill GV. 'Microalbuminuric anaemia'—the relationship between haemoglobin levels and albuminuria in diabetes. Diabetes research and clinical practice. 2009;85(2):179–82. Epub 2009/06/02. 10.1016/j.diabres.2009.04.028 .
    1. KDIGO. 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease.. Available from: .
    1. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Archives of internal medicine. 2005;165(8):947–53. Epub 2005/04/27. 10.1001/archinte.165.8.947 .
    1. Bello AK, Hemmelgarn B, Lloyd A, James MT, Manns BJ, Klarenbach S, et al. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clinical journal of the American Society of Nephrology: CJASN. 2011;6(6):1418–26. Epub 2011/04/30. 10.2215/cjn.09741110 ; PubMed Central PMCID: PMCPmc3109940.
    1. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney international. 2011;80(1):93–104. Epub 2011/02/04. 10.1038/ki.2010.531 .
    1. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106(14):1777–82. Epub 2002/10/03. .
    1. Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2013;62(6):1102–8. Epub 2013/09/18. 10.1053/j.ajkd.2013.07.013 ; PubMed Central PMCID: PMCPmc3840083.
    1. Oh KH, Park SK, Park HC, Chin HJ, Chae DW, Choi KH, et al. KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC nephrology. 2014;15:80 Epub 2014/06/03. 10.1186/1471-2369-15-80 ; PubMed Central PMCID: PMCPmc4050398.
    1. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009;150(9):604–12. Epub 2009/05/06. ; PubMed Central PMCID: PMCPmc2763564.
    1. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public health nutrition. 2009;12(4):444–54. Epub 2008/05/24. 10.1017/s1368980008002401 .
    1. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. Journal of the American College of Cardiology. 2002;39(11):1780–6. Epub 2002/06/01. .
    1. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA: the journal of the American Medical Association. 2001;286(4):421–6. Epub 2001/07/31. .
    1. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney international. 2011;80(1):17–28. Epub 2010/12/15. 10.1038/ki.2010.483 .
    1. Howard RL, Buddington B, Alfrey AC. Urinary albumin, transferrin and iron excretion in diabetic patients. Kidney international. 1991;40(5):923–6. Epub 1991/11/01. .
    1. Prinsen BH, de Sain-van der Velden MG, Kaysen GA, Straver HW, van Rijn HJ, Stellaard F, et al. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. Journal of the American Society of Nephrology: JASN. 2001;12(5):1017–25. Epub 2001/04/24. .
    1. Thomas MC, Cooper ME, Rossing K, Parving HH. Anaemia in diabetes: Is there a rationale to TREAT? Diabetologia. 2006;49(6):1151–7. Epub 2006/04/06. 10.1007/s00125-006-0215-6 .
    1. Thomas MC, Cooper ME, Tsalamandris C, MacIsaac R, Jerums G. Anemia with impaired erythropoietin response in diabetic patients. Archives of internal medicine. 2005;165(4):466–9. Epub 2005/03/02. 10.1001/archinte.165.4.466 .
    1. Thomas MC. Anemia in diabetes: marker or mediator of microvascular disease? Nature Clinical Practice Nephrology. 2007;3(1):20–30.
    1. Thomas M, Tsalamandris C, MacIsaac R, Jerums G. Anaemia in diabetes: an emerging complication of microvascular disease. Current diabetes reviews. 2005;1(1):107–26. Epub 2008/01/29. .
    1. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney international. 1999;56(5):1627–37. Epub 1999/11/26. 10.1046/j.1523-1755.1999.00721.x .
    1. Unal A, Kocyigit I, Arikan T, Sipahioglu MH, Tokgoz B, Oymak O. Microalbuminuria is associated with high prevalence of anemia in renal transplant recipients. Transplantation proceedings. 2013;45(3):949–52. Epub 2013/04/30. 10.1016/j.transproceed.2013.02.066 .
    1. Okada H, Hasegawa G, Tanaka M, Osaka T, Shiotsu Y, Narumiya H, et al. Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease. PloS one. 2015;10(5):e0129192 Epub 2015/05/30. 10.1371/journal.pone.0129192 ; PubMed Central PMCID: PMCPmc4449165.
    1. Ajmal A, Gessert CE, Johnson BP, Renier CM, Palcher JA. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels. BMC research notes. 2013;6:443 Epub 2013/11/06. 10.1186/1756-0500-6-443 .
    1. Leshem-Rubinow E, Steinvil A, Zeltser D, Berliner S, Rogowski O, Raz R, et al. Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clinic proceedings. 2012;87(12):1189–95. Epub 2012/11/13. 10.1016/j.mayocp.2012.07.020 ; PubMed Central PMCID: PMCPmc3547548.
    1. Lambers Heerspink HJ, Gansevoort RT, Brenner BM, Cooper ME, Parving HH, Shahinfar S, et al. Comparison of different measures of urinary protein excretion for prediction of renal events. Journal of the American Society of Nephrology: JASN. 2010;21(8):1355–60. Epub 2010/07/17. 10.1681/asn.2010010063 ; PubMed Central PMCID: PMCPmc2938598.

Source: PubMed

3
Prenumerera